Stock AREC ARECOR THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Market Closed - London S.E.
Other stock markets
 11:35:08 2024-05-31 am EDT 		5-day change 1st Jan Change
159 GBX +0.95% Intraday chart for Arecor Therapeutics plc +0.32% -12.88%
May. 21 Transcript : Arecor Therapeutics plc - Special Call
May. 20 Arecor Therapeutics plc Announces Its Ultra-Concentrated, Ultra-Rapid Acting Insulins CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Arecor Therapeutics plc Announces Its Ultra-Concentrated, Ultra-Rapid Acting Insulins
CI
Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study
MT
Arecor Therapeutics hails positive profile for insulin AT278
AN
EARNINGS AND TRADING: Michelmersh continues with positive order intake
AN
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Posts FY23 Revenue GBP4.6M
MT
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Reports FY23 Loss GBP-0.28
MT
Arecor Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Arecor Therapeutics collaborates with Medtronic on novel insulin
AN
Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development
MT
Arecor and Medtronic Diabetes Collaboration
CI
Arecor Therapeutics delays publication of 2023 results
AN
Arecor to develop "holy grail" diabetes treatment with partner TRx
AN
Arecor Therapeutics plc and Trx Biosciences Limited Announces Research Collaboration for the Formulation Development of an Oral GLP-1 Receptor Agonist Product
CI
EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV
AN
Arecor Therapeutics hails Arestat as 2023 performance "strong"
AN
Arecor pleased as investee Inhibrx sells therapy to Sanofi
AN
Patent boosts for DG Innovate and Arecor Therapeutics
AN
Arecor Therapeutics Gains European Patent for Insulin Product Formulations
MT
Arecor expands speciality hospital collaboration with partner
AN
Arecor Therapeutics plc Expands Ongoing, Exclusive Formulation Study Collaboration with the Pharmaceutical Division of One of the World's Largest Chemicals Marketing and Pharmaceuticals Companies
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AREC Stock
  4. News Arecor Therapeutics plc
  5. Highlights